ANN ARBOR, Mich., Nov. 6, 2006 (PRIMEZONE) -- Pipex Therapeutics, Inc. (OTCBB:SFPH), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and fibrotic diseases, announced today that it has merged with Sheffield Pharmaceuticals, Inc.
